패혈증 진단 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Sepsis Diagnostics Market size is expected to reach USD 1.56 Billion in 2034 from USD 0.79 Billion (2025) growing at a CAGR of 7.89% during 2026-2034.

The Global Sepsis Diagnostics Market is expanding due to the rising incidence of hospital-acquired infections and the growing need for early detection of life-threatening conditions. Sepsis requires rapid diagnosis to prevent organ failure and mortality. Increasing awareness among healthcare providers and advancements in diagnostic technologies are driving demand. The use of biomarkers, molecular diagnostics, and automated blood culture systems has improved the speed and accuracy of sepsis detection.

Key growth drivers include the increasing geriatric population, rising cases of chronic diseases, and growing hospital admissions worldwide. Government initiatives to reduce sepsis-related deaths and improve critical care management are further supporting market growth. Technological developments such as point-of-care testing and AI-based diagnostic tools are enhancing efficiency. Hospitals and diagnostic laboratories are investing in advanced systems to reduce turnaround time and improve patient outcomes.

Looking ahead, the market is expected to witness strong growth with the integration of digital health solutions and real-time monitoring systems. Rapid diagnostic kits and portable testing devices will likely gain popularity, especially in emergency settings. Emerging markets are projected to adopt advanced technologies as healthcare awareness rises. Continuous innovation and improved access to early diagnostic solutions will strengthen the future prospects of the Sepsis Diagnostics Market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Blood Culture Media
• Instruments
• Assay Kits & Reagents
• Software

By Technology

• Microbiology
• Molecular Diagnostics
• Immunoassays
• Flow Cytometry

By Method Type

• Conventional Diagnostics
• Automated Diagnostics

By Pathogen Type

• Bacterial Sepsis
• Fungal Sepsis
• Others

By End-use

• Hospitals
• Diagnostic Centres
• Clinics
• Others

COMPANIES PROFILED

• Abbott Laboratories, BioMrieux SA, Thermo Fisher Scientific Inc, Becton, Dickinson and Company, Bruker Corporation, Beckman Coulter Inc, T2 Biosystems Inc, Nanosphere Inc, HoffmannLa Roche Ltd, Danaher Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SEPSIS DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Blood Culture Media Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Assay Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Microbiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Immunoassays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Flow Cytometry Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SEPSIS DIAGNOSTICS MARKET: BY METHOD TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Method Type
• 6.2. Conventional Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Automated Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SEPSIS DIAGNOSTICS MARKET: BY PATHOGEN TYPE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Pathogen Type
• 7.2. Bacterial Sepsis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Fungal Sepsis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SEPSIS DIAGNOSTICS MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Diagnostic Centres Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL SEPSIS DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Technology
  • 9.2.3 By Method Type
  • 9.2.4 By Pathogen Type
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Technology
  • 9.3.3 By Method Type
  • 9.3.4 By Pathogen Type
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Technology
  • 9.4.3 By Method Type
  • 9.4.4 By Pathogen Type
  • 9.4.5 By End-use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Technology
  • 9.5.3 By Method Type
  • 9.5.4 By Pathogen Type
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Technology
  • 9.6.3 By Method Type
  • 9.6.4 By Pathogen Type
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL SEPSIS DIAGNOSTICS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Abbott Laboratories
  • 11.2.2 BioMAfA(C)Rieux SA
  • 11.2.3 Thermo Fisher Scientific Inc
  • 11.2.4 Becton
  • 11.2.5 Dickinson And Company
  • 11.2.6 Bruker Corporation
  • 11.2.7 Beckman Coulter Inc
  • 11.2.8 T2 Biosystems Inc
  • 11.2.9 Nanosphere Inc
  • 11.2.10 Hoffmann-La Roche Ltd
  • 11.2.11 Danaher Corporation